Literature DB >> 2837626

The effect of cooling on in vitro vascular prostacyclin and platelet thromboxane A2 synthesis: relevance to cold-induced pathology.

J Y Jeremy1, D P Mikhailidis, R A Hutton, P Dandona.   

Abstract

The effect of cooling (at 27 degrees C) on the synthesis of prostacyclin (PGI2) by rat aortic rings, thromboxane A2 (TXA2) synthesis by human platelets and phosphodiesterase activity in human platelets was investigated. Cooling induced a significant reduction in both PGI2 synthesis by rat aortic rings and TXA2 synthesis by human platelets, but the inhibition of the former was proportionately greater. Platelet phosphodiesterase activity decreased, with a subsequent increase in intraplatelet c-AMP content. Diminished PGI2 synthesis/release associated with the previously described diminution in the sensitivity of platelets to PGI2 after cooling probably contributes to the hyperaggregability of platelets at lower temperatures. This occurs in spite of the potential antiaggregatory effect of diminished TXA2 synthesis by platelets and the increase in intraplatelet c-AMP. These observations are relevant to the pathogenesis of hyperaggregability of platelets in Raynaud's syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837626

Source DB:  PubMed          Journal:  Microcirc Endothelium Lymphatics        ISSN: 0740-9451


  3 in total

1.  Cold exposure exacerbates the development of diabetic polyneuropathy in the rat.

Authors:  Lora J Kasselman; Aristidis Veves; Christopher H Gibbons; Seward B Rutkove
Journal:  Exp Diabetes Res       Date:  2010-01-14

2.  The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome.

Authors:  C S Lau; F Khan; M McLaren; A Bancroft; M Walker; J J Belch
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Seasonal variation of platelets in a cohort of Italian blood donors: a preliminary report.

Authors:  Massimo Gallerani; Roberto Reverberi; Raffaella Salmi; Michael H Smolensky; Roberto Manfredini
Journal:  Eur J Med Res       Date:  2013-09-17       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.